A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

NCT06868628 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: Foralumab Nasal

Sponsor

Tiziana Life Sciences LTD